Stitch Fix, Inc.·4

Jan 22, 9:22 PM ET

O'Connor Casey 4

Research Summary

AI-generated summary

Updated

Stitch Fix (SFIX) CLO Casey O'Connor Exercises Options, Sells Shares

What Happened Casey O'Connor, Chief Legal Officer of Stitch Fix (SFIX), exercised stock options and sold shares over Jan 20–22, 2026. She exercised options to acquire a total of 68,752 shares at an exercise price of $3.80 per share (total cost ≈ $261,258). Separately, she disposed of 138,752 shares in open‑market sales for aggregate proceeds of about $725,903 (weighted average sale prices reported). The filings show both the option exercises and matching derivative disposals (reported at $0) as part of the same sequence of transactions.

Key Details

  • Transaction dates: Jan 20, 2026; Jan 21, 2026; Jan 22, 2026.
  • Options exercised: 13,641 (1/20), 13,852 (1/21), 41,259 (1/22) — total 68,752 shares at $3.80 each (≈ $261,258).
  • Shares sold: 83,641 (1/20) at weighted avg $5.16 (range $4.91–$5.39), 13,852 (1/21) at weighted avg $5.34 (range $5.34–$5.345), 41,259 (1/22) at weighted avg $5.34 — total sold 138,752 shares for ≈ $725,903.
  • Reporting mechanics: derivative disposals shown at $0 reflect the reporting of exercised/options- converted shares; these are not separate cash transactions.
  • Plan/footnotes: Exercises and sales were executed pursuant to a Rule 10b5‑1 plan entered Jan 9, 2025 (pre‑planned trades). The sales prices are reported as weighted averages; the filer will provide per‑trade price details on request. The underlying options were fully vested per the footnote.
  • Timeliness: Form 4 was filed Jan 22, 2026 covering transactions on Jan 20–22; filing appears to be timely.

Context

  • This sequence shows option exercises followed by sales; because the sales were made under a pre‑existing 10b5‑1 plan, they are likely pre‑scheduled trades rather than ad‑hoc market timing. Exercises at $3.80 followed by sales at ~$5.16–$5.34 produced a gain on the shares sold (before taxes and fees).
  • For retail investors: purchases (insider buys) are generally more indicative of a bullish signal than routine option exercises and plan‑based sales. These filings are factual disclosures of insider activity and do not by themselves indicate the insider's current view on the company.